These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18425827)

  • 21. Magnetic resonance imaging of liver metastases: experimental comparison of anionic and conventional superparamagnetic iron oxide particles with a hepatobiliary contrast medium during dynamic and uptake phases.
    Kaufels N; Korn R; Wagner S; Schink T; Hamm B; Taupitz M; Schnorr J
    Invest Radiol; 2008 Jul; 43(7):496-503. PubMed ID: 18580332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ferumoxtran-10, a superparamagnetic iron oxide as a magnetic resonance enhancement agent for imaging lymph nodes: a phase 2 dose study.
    Hudgins PA; Anzai Y; Morris MR; Lucas MA
    AJNR Am J Neuroradiol; 2002 Apr; 23(4):649-56. PubMed ID: 11950660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent.
    Bourrinet P; Bengele HH; Bonnemain B; Dencausse A; Idee JM; Jacobs PM; Lewis JM
    Invest Radiol; 2006 Mar; 41(3):313-24. PubMed ID: 16481915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel formulation for superparamagnetic iron oxide (SPIO) particles enhancing MR lymphography: comparison of physicochemical properties and the in vivo behaviour.
    Lind K; Kresse M; Debus NP; Müller RH
    J Drug Target; 2002 May; 10(3):221-30. PubMed ID: 12075823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast-enhanced 3D-TOF MRA of peripheral vessels: intravascular versus extracellular MR contrast media.
    Engelbrecht MR; Saeed M; Wendland MF; Canet E; Oksendal AN; Higgins CB
    J Magn Reson Imaging; 1998; 8(3):616-21. PubMed ID: 9626876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacokinetics of the lymphotropic nanoparticle MRI contrast agent ferumoxtran-10.
    Islam T; Wolf G
    Cancer Biomark; 2009; 5(2):69-73. PubMed ID: 19414923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: original research original research.
    Simon GH; Raatschen HJ; Wendland MF; von Vopelius-Feldt J; Fu Y; Chen MH; Daldrup-Link HE
    Acad Radiol; 2005 Sep; 12(9):1190-7. PubMed ID: 16099684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steady-state equilibrium phase inversion recovery ON-resonant water suppression (IRON) MR angiography in conjunction with superparamagnetic nanoparticles. A robust technique for imaging within a wide range of contrast agent dosages.
    Gitsioudis G; Stuber M; Arend I; Thomas M; Yu J; Hilbel T; Giannitsis E; Katus HA; Korosoglou G
    J Magn Reson Imaging; 2013 Oct; 38(4):836-44. PubMed ID: 23418107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visualization of lymphatic basin from the tumor using magnetic resonance lymphography with superparamagnetic iron oxide in patients with thoracic esophageal cancer.
    Ishiyama K; Motoyama S; Tomura N; Sashi R; Imano H; Ogawa J; Narita K; Watarai J
    J Comput Assist Tomogr; 2006; 30(2):270-5. PubMed ID: 16628046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of two blood pool contrast agents for 0.5-T MR angiography: experimental study in rabbits.
    Clarke SE; Weinmann HJ; Dai E; Lucas AR; Rutt BK
    Radiology; 2000 Mar; 214(3):787-94. PubMed ID: 10715047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging.
    Briley-Saebo K; Bjørnerud A; Grant D; Ahlstrom H; Berg T; Kindberg GM
    Cell Tissue Res; 2004 Jun; 316(3):315-23. PubMed ID: 15103550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a new ultrasmall superparamagnetic iron oxide contrast agent Clariscan, (NC100150) for MRI of renal perfusion: experimental study in an animal model.
    Bachmann R; Conrad R; Kreft B; Luzar O; Block W; Flacke S; Pauleit D; Träber F; Gieseke J; Saebo K; Schild H
    J Magn Reson Imaging; 2002 Aug; 16(2):190-5. PubMed ID: 12203767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicenter clinical trial of ultrasmall superparamagnetic iron oxide in the evaluation of mediastinal lymph nodes in patients with primary lung carcinoma.
    Nguyen BC; Stanford W; Thompson BH; Rossi NP; Kernstine KH; Kern JA; Robinson RA; Amorosa JK; Mammone JF; Outwater EK
    J Magn Reson Imaging; 1999 Sep; 10(3):468-73. PubMed ID: 10508310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AMI-227-enhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodes.
    Vassallo P; Matei C; Heston WD; McLachlan SJ; Koutcher JA; Castellino RA
    Radiology; 1994 Nov; 193(2):501-6. PubMed ID: 7972768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of a blood-pool contrast agent for MR-guided vascular procedures: feasibility of ultrasmall superparamagnetic iron oxide particles.
    Wacker FK; Wendt M; Ebert W; Hillenbrandt C; Wolf KJ; Lewin JS
    Acad Radiol; 2002 Nov; 9(11):1251-4. PubMed ID: 12449357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of synovial macrophages in an experimental rabbit model of antigen-induced arthritis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging.
    Lutz AM; Seemayer C; Corot C; Gay RE; Goepfert K; Michel BA; Marincek B; Gay S; Weishaupt D
    Radiology; 2004 Oct; 233(1):149-57. PubMed ID: 15333767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of mechanisms influencing the accumulation of ultrasmall superparamagnetic iron oxide particles in lymph nodes.
    Mühler A; Zhang X; Wang H; Lawaczeck R; Weinmann HJ
    Invest Radiol; 1995 Feb; 30(2):98-103. PubMed ID: 7540165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MR imaging of mediastinal lymph nodes: evaluation using a superparamagnetic contrast agent.
    Pannu HK; Wang KP; Borman TL; Bluemke DA
    J Magn Reson Imaging; 2000 Dec; 12(6):899-904. PubMed ID: 11105028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative diagnosis of lymph node metastases in gastric cancer by magnetic resonance imaging with ferumoxtran-10.
    Tatsumi Y; Tanigawa N; Nishimura H; Nomura E; Mabuchi H; Matsuki M; Narabayashi I
    Gastric Cancer; 2006; 9(2):120-8. PubMed ID: 16767368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of ultrasmall ferric oxide (Sinerem) particles as a magnetic resonance contrast substance for imaging lymph nodal metastases in cancer of the head and neck].
    Sviridov NK; Napolov IuK; Bolotova EN; Iakobs LV
    Vestn Rentgenol Radiol; 2004; (3):63-4. PubMed ID: 15587888
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.